Tagged as: HHS

HHS Seeks Public Comments on Trump Administration's Plan to Lower Drug Prices

Last week the Department of Health and Human Services (HHS) issued a request for comments on the Trump administration’s plan to lower drug prices.  The HHS blueprint to lower drug prices includes improving competition by promoting innovation and competition for biologics.  According to HHS, “FDA will issue new policies to improve availability, competitiveness, and adoption of…

Read More